Mediwound announces presentation on escharex at the advanced wound care summit in boston on july 13

Yavne, israel, july 08, 2022 (globe newswire) -- mediwound ltd. (nasdaq: mdwd), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced an oral presentation at the advanced wound care summit taking place on july 13-14, 2022 in boston, ma.
MDWD Ratings Summary
MDWD Quant Ranking